Kolon TissueGene, Inc. (950160.KQ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−11.2x

Market Cap

KRW 1.38T

MomentumView details →

1D Return

−5.53%

YTD Return

−78.52%

RSI (14)

31.0

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−11.2x

Market Cap

KRW 1.38T

RSI (14)

31.0

MomentumView details →

1D Return

−5.53%

YTD Return

−78.52%

ProfitabilityView details →

Gross Margin

8.00%

Net Margin

−3811.18%

EBITDA Margin

−2526.79%

ROE (TTM)

−88.49%

ROA (TTM)

−35.20%

Asset Turnover

0.01x

GrowthView details →

Revenue YoY

−13.54%

EPS YoY

−98.36%

FCF YoY

+52.21%

Revenue CAGR 3Y

−18.31%

EPS CAGR 3Y

—

EBITDA YoY

−38.33%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.31x

Current Ratio

0.33x

Quick Ratio

0.33x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

4.76B

Net Income (TTM)

−181.53B

Op. CF (TTM)

−17.36B

Latest newsMore news →

No recent news for 950160.KQ.

Similar companies

Orum Therapeutics, Inc.475830.KQ OliX Pharmaceuticals,Inc226950.KQ Onconic Therapeutics476060.KQ Voronoi, Inc.310210.KQ D&D Pharmatech347850.KQ SK bioscience Co.,Ltd.302440.KS Find similar companies →

Latest newsMore news →

No recent news for 950160.KQ.